Ayurvedic supplement and FMCG giant Dabur India is conducting a three-month clinical trial to test if its chyawanprash formula could help prevent healthy individuals from contracting COVID-19.
India’s three-week lockdown has affected the nutrition and health businesses on multiple fronts, most directly on the production, supply chain, and e-commerce delivery, companies including FMCG giant and ayurvedic medicine specialist Dabur have told us.